mirtazapine has been researched along with Arthritis, Rheumatoid in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishigori, R | 1 |
| Warabi, Y | 1 |
| Shishido-Hara, Y | 1 |
| Nakamichi, K | 1 |
| Nakata, Y | 1 |
| Komori, T | 1 |
| Isozaki, E | 1 |
1 other study available for mirtazapine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis.
Topics: Aged; Antimalarials; Arthritis, Rheumatoid; Brain; CD4-CD8 Ratio; Cerebellum; Female; Humans; Immuno | 2019 |